Vancouver, British Columbia–(Newsfile Corp. – May 28, 2020) – BioHarvest Sciences Inc. (CSE: BHSC) (the “Company”) is pleased to announce that it has retained Hybrid Financial Ltd. (“Hybrid”) to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for BioHarvest Sciences Inc. and to broaden the Company’s reach within the investment community.
Hybrid has agreed to comply with all applicable securities laws and the policies of the Canadian Securities Exchange (the “CSE”) in providing the Services.
Hybrid has been engaged by the Company for an initial period of 6 months and then shall be renewed for successive three (3) month periods thereafter, unless terminated by the Company in accordance with the Agreement. Hybrid will be compensated at a monthly fee of $15,000.00, plus applicable taxes, during the Initial Term.
Dr. Zaki Rakib, Chief Executive Officer at BioHarvest Sciences Inc. commented, “BioHarvest Sciences is a Biotech innovator with a unique platform technology for plants cells growth capable of addressing multiple high growth verticals. These include but not limited to the Nutraceuticals and Cannabis markets. It is essential to constantly communicate with investors and shareholders the Company’s capabilities, potential and performance. We are happy to have a world class team like Hybrid Financial assisting us in such task.”
About Hybrid Financial Ltd.:
Hybrid is a sales and distribution company that actively connects issuers to the investment community across North America. Using a data driven approach, Hybrid provides its clients with comprehensive coverage of both American and Canadian markets. Hybrid Financial has offices in Toronto and Montreal.
About BioHarvest Sciences Inc.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent protected Biofarming technology. It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. The technology has been already validated by Vinia, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest. By adapting this technology to the Cannabis plant, and building adequate cells production capacity, BioHarvest Sciences Inc.’s objective is to become the leading supplier of Cannabis for both the medicinal and recreational legal use. See the following hyperlink for a visual description of our Biofarming technology: https://www.youtube.com/watch?v=c7pxqAoTf5g
BioHarvest Sciences Inc.
Dr. Zaki Rakib
For further information, please contact:
Dave Ryan, President & Director
Phone: 1 (604) 622-1186
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
Neither Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56761